Immunity

NextPlat Opens OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China on March 1st

Retrieved on: 
Wednesday, February 28, 2024

COCONUT GROVE, Fla., Feb. 28, 2024 /PRNewswire/ -- NextPlat Corp (NASDAQ: NXPL, NXPLW) ("NextPlat" or the "Company"), a global e-Commerce provider, today announced that its exclusive OPKO Health-branded storefront on Alibaba Group Holding Limited's ("Alibaba")(NYSE: BABA) Tmall Global in China has received all required approvals and is scheduled to officially launch on March 1st.

Key Points: 
  • Under terms of the exclusive joint e-commerce development agreement with OPKO Health Europe ("OPKO"), a subsidiary of OPKO Health, Inc. (NASDAQ: OPK), NextPlat is officially launching the OPKO Health-branded online storefront on Alibaba's Tmall Global e-commerce platform in China.
  • All in-country sales and marketing support for the OPKO Health Tmall Global e-commerce site is being provided by a local online specialist, a Tmall Global-preferred merchant partner.
  • The sales of OPKO products in China will be managed through NextPlat and will be made available to purchase for Chinese consumers through Tmall Global.
  • Tmall Global is China's leading import e-commerce platform where consumers can access over 46,000 international brands.

Valens Semiconductor Reports Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Wednesday, February 28, 2024

HOD HASHARON, Israel, Feb. 28, 2024 /PRNewswire/ -- Valens Semiconductor Ltd. (NYSE: VLN), a leader in high-performance connectivity, today reported financial results for the fourth quarter and full year ended December 31, 2023.

Key Points: 
  • Fourth quarter revenues reached $21.9 million, and net income was $2.8 million; Full year 2023 revenues reached $84.2 million with automotive revenues reaching an annual record high
    HOD HASHARON, Israel, Feb. 28, 2024 /PRNewswire/ -- Valens Semiconductor Ltd. (NYSE: VLN), a leader in high-performance connectivity, today reported financial results for the fourth quarter and full year ended December 31, 2023.
  • "Valens Semiconductor demonstrated both its resilience and innovation in 2023.
  • Fourth quarter 2023 revenues reached $21.9 million, compared to $23.5 million in the fourth quarter of 2022
    - GAAP gross margin was 61.7% for the fourth quarter 2023 (non-GAAP gross margin was 63.1%).
  • Valens Semiconductor will host a conference call today, Wednesday, February 28, 2024, at 8:30 a.m. Eastern Time (ET) to discuss its fourth quarter and full year 2023 financial results and business outlook.

Mexico is suing US gun-makers for arming its gangs − and a US court could award billions in damages

Retrieved on: 
Friday, February 16, 2024

The government of Mexico is suing U.S. gun-makers for their role in facilitating cross-border gun trafficking that has supercharged violent crime in Mexico.

Key Points: 
  • The government of Mexico is suing U.S. gun-makers for their role in facilitating cross-border gun trafficking that has supercharged violent crime in Mexico.
  • To understand why, let’s begin with some background about the federal law that protects the gun industry from civil lawsuits.

Gun industry immunity

  • Importantly, there are limits to this immunity shield.
  • Mexico’s lawsuit alleges that U.S. gun-makers aided and abetted illegal weapons sales to gun traffickers in violation of federal law.

Mexico’s allegations

  • Mexico also points to industry marketing that promises buyers a tactical military experience for civilians.
  • In short, Mexico claims that illegal gun trafficking isn’t just an unwanted byproduct of the industry’s design choices, marketing campaigns and distribution practices.
  • Instead, according to the lawsuit, feeding demand for illegal weapons is central to the industry’s business model.

The next legal steps

  • In January 2024, a federal appeals court in Massachusetts decided that Mexico’s allegations, if true, would deprive the gun-makers of immunity, and it sent the case back to trial court.
  • Mexico now needs to produce evidence to prove its allegations that the industry is not only aware of but actively facilitates illegal gun trafficking.
  • For their part, the gun-makers have asked the trial judge to put the case on hold while they pursue an appeal to the U.S. Supreme Court.

High stakes for the industry

  • Even if the case were to settle for much less, a victory by Mexico would provide a template for a wave of future lawsuits that could change the way the gun industry operates.
  • Similar theories about dangerous product designs, irresponsible marketing and reckless distribution practices in opioid litigation have transformed the pharmaceutical industry.


Timothy D. Lytton has provided expert consulting services to law firms representing gun violence victims.

“The Weekly Check-Up Podcast” brings acclaimed healthcare talk radio show to larger audience

Retrieved on: 
Thursday, February 15, 2024

“Having produced more than a decade of ‘The Weekly Check-Up’ radio content, it's exciting to introduce a new platform to share the latest healthcare information with as many listeners as possible,” says host Dr. Bruce Feinberg.

Key Points: 
  • “Having produced more than a decade of ‘The Weekly Check-Up’ radio content, it's exciting to introduce a new platform to share the latest healthcare information with as many listeners as possible,” says host Dr. Bruce Feinberg.
  • Since the show began in 2011, Dr. Feinberg has amassed more than 500 hours of content featuring countless thought-provoking questions from listeners.
  • Dr. Feinberg will pair some of the most compelling content from the show’s archives with new, invaluable and practical answers and perspectives.
  • New episodes of “The Weekly Check-Up Podcast” will appear every other week on all major podcast platforms including Spotify, Apple Podcasts, and Google Podcasts.

Disinformation threatens global elections – here’s how to fight back

Retrieved on: 
Thursday, February 15, 2024

Others think concern over disinformation is just a moral panic or merely a symptom rather than the cause of our societal ills.

Key Points: 
  • Others think concern over disinformation is just a moral panic or merely a symptom rather than the cause of our societal ills.
  • Given that nearly 25% of elections are decided by a margin of under 3%, mis- and disinformation can have important influence.
  • By contrast, among prior Obama voters who believed at least two fake headlines about Clinton, only 17% voted for her.
  • There are more indirect consequences of disinformation too, such as eroding public trust and participation in elections.

The power of prebunking

  • In contrast, “prebunking” is a new way to prevent false beliefs from forming in the first place.
  • Such “inoculation” involves warning people not to fall for a false narrative or propaganda tactic, together with an explanation as to why.
  • Misinforming rhetoric has clear markers, such as scapegoating or use of false dichotomies (there are many others), that people can learn to identify.
  • Like a medical vaccine, the prebunk exposes the recipient to a “weakened dose” of the infectious agent (the disinformation) and refutes it in a way that confers protection.
  • For example, we created an online game for the Department of Homeland Security to empower Americans to spot foreign influence techniques during the 2020 presidential election.
  • Lee McIntyre advises the UK Government on how to fight disinformation.
  • He also receives funding from Jigsaw (a technology incubator created by Google) and from UK Research and Innovation (through EU Horizon replacement funding grant number 10049415).

The ‘jab market’ of private COVID vaccines is a good thing for public health – but not for health inequality

Retrieved on: 
Thursday, February 15, 2024

Yes.

Key Points: 
  • Yes.
  • Yes.

What are the benefitS?

  • That’s because the more people that are able to keep up to date with COVID boosters, the higher the level of immunity across the population.
  • High booster coverage can help protect against surging cases or potential new variants, and help lower levels of COVID-related sickness across the population.
  • Crucially, though, increased booster coverage could help reduce rates of long COVID – the risk of which rises with multiple re-infections .

But will people buy them?

  • Along with colleagues, last year I conducted research on attitudes to private COVID boosters in Wales.
  • If the private market for the flu jab is anything to go by, then ease of access might give COVID uptake rates a boost.
  • Ultimately it remains to be seen how much demand there will be for private COVID vaccines.

Private vaccines could worsen health inequalities

  • At a price of £45 per jab, those on low income are much less likely to be able to afford them.
  • As such, the private sale of COVID vaccines will only serve to perpetuate health inequalities.
  • They are also more likely to be negatively impacted by winter pressures and health service crises.

People should be free to choose to get vaccinated

  • Vaccine passports and mandatory vaccination for health and social care workers were strongly opposed by some on the grounds that they took away people’s choice to not get vaccinated.
  • Surely the same arguments made against requiring people to get vaccinated should also apply to excluding people from getting vaccinated?


Simon Nicholas Williams has received funding from Senedd Cymru, Public Health Wales and the Wales Covid Evidence Centre for research on COVID-19, and has consulted for the World Health Organization. However, this article reflects the views of the author only, in his academic capacity at Swansea University, and no funding or organizational bodies were involved in the writing or content of this article.

Global Ready to Drink Tea and Coffee Market Report, 2024: Market to Reach $172.28 Billion by 2030 - On-the-Go Lifestyle Fuels Surge in RTD Tea and Coffee Consumption - ResearchAndMarkets.com

Retrieved on: 
Thursday, February 15, 2024

Ready-to-drink Drink Tea and Coffee Market will reach US$ 172.28 Billion by 2030.

Key Points: 
  • Ready-to-drink Drink Tea and Coffee Market will reach US$ 172.28 Billion by 2030.
  • The RTD tea and coffee market is shifting in quality to keep pace with increased interest in healthier ingredients and authentic experiences.
  • Health advantages coupled with RTD tea and coffee consumption drive consumers' attention, particularly the aging population, further boosting consumer inclination towards RTD tea and coffee.
  • Product Category segments the RTD Tea and Coffee Market into RTD Tea and RTD Coffee.

Affordability and Gut Health Predicted as Leading Food Purchase Drivers in 2024

Retrieved on: 
Thursday, February 15, 2024

NEW YORK, Feb. 15, 2024 /PRNewswire/ -- In the ever-evolving food and nutrition space, affordability and gut health are positioned to take center stage as leading drivers of consumer purchasing decisions in 2024. These insights come from the annual Today's Dietitian and Pollock Communications "What's Trending in Nutrition" survey of 564 Registered Dietitian Nutritionists (RDNs), offering a glimpse into the shifting landscape of what we eat and why as consumers increasingly prioritize both their well-being and their wallets.

Key Points: 
  • NEW YORK, Feb. 15, 2024 /PRNewswire/ -- In the ever-evolving food and nutrition space, affordability and gut health are positioned to take center stage as leading drivers of consumer purchasing decisions in 2024.
  • Call It a Gut Feeling: Gut Health Climbs the List While Affordability & Convenience Maintain Top Spots as Consumer Purchase Drivers
    As consumers navigate recent increases in grocery prices, RDNs predict that affordability will be an important driver of consumer purchases.
  • Research into the benefits of a healthy microbiome, from mood to weight management has sparked interest in foods that support gut health.
  • The COVID-19 pandemic demonstrated a need to regularly protect immune health, and consumers continue to shop for foods that support immunity.

Industry-Leading Functional Mushroom Brand, FreshCap, Launches Exclusive Brick-and-Mortar Retail Partnership with GNC

Retrieved on: 
Thursday, February 15, 2024

CHICAGO, Feb. 15, 2024 /PRNewswire/ -- FreshCap, the functional mushroom brand utilizing whole fruiting bodies to support a wide range of powerful benefits, announced today a nationwide partnership with GNC. The leading nutritional supplement retailer will have brick-and-mortar exclusivity to FreshCap's best-selling line of high-quality functional mushroom products, all of which are non-GMO, certified organic and analytically tested to guarantee high levels of active beneficial compounds. The products will be available online immediately and rolled out to 1500 retail locations in March.

Key Points: 
  • The products will be available online immediately and rolled out to 1500 retail locations in March.
  • GNC will carry four of FreshCap's beloved mushroom-based products, each formulated to promote health and longevity by increasing immunity, stress relief, cognitive function and more.
  • The GNC-exclusive products include:
    Lion's Mane Capsules ($27.99, 60-count) – the "brain mushroom" used for cognition, focus, and mental clarity.
  • Now the leading voice in mushroom education, FreshCap has a cult following on YouTube with 466K followers and regular programming including "The Mushroom Show."

ProPhase Labs Announces Preliminary Positive Results for Dietary Supplement Equivir

Retrieved on: 
Wednesday, February 14, 2024

Garden City, NY, Feb. 14, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation biotech, genomics and diagnostics company, today announced positive preliminary results from its Equivir dietary supplement comprehensive trial. Preliminary results indicate that this innovative OTC dietary supplement has the potential to support and maintain immunity, which – if confirmed at the end of the clinical trial program – may help reduce both the frequency and severity of upper respiratory illnesses including the common cold, flu, and Covid-19.

Key Points: 
  • Commercialization of Equivir anticipated after second trial is completed in Q2, 2024
    Garden City, NY, Feb. 14, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation biotech, genomics and diagnostics company, today announced positive preliminary results from its Equivir dietary supplement comprehensive trial.
  • Each study enrolls 150 participants, randomly assigned to receive either Equivir or a placebo, with their health monitored over a 180-day period.
  • Preliminary results are as follows:
    Overall, in the initial 150 patient group there were approximately 46 incidences of upper respiratory viral infections.
  • Equivir is being developed with plans to market as an OTC dietary supplement.